Cargando…
Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
Background Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously examined intermediate-risk patients from hospital data and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007389/ https://www.ncbi.nlm.nih.gov/pubmed/32814350 http://dx.doi.org/10.1055/a-1217-0155 |
_version_ | 1783672477430317056 |
---|---|
author | Robbins, Emma C. Wooldrage, Kate Stenson, Iain Pack, Kevin Duffy, Stephen Weller, David Levin, Theodore Conell, Carol Wright, Suzanne Nickerson, Claire Martin, Jessica Cross, Amanda J. |
author_facet | Robbins, Emma C. Wooldrage, Kate Stenson, Iain Pack, Kevin Duffy, Stephen Weller, David Levin, Theodore Conell, Carol Wright, Suzanne Nickerson, Claire Martin, Jessica Cross, Amanda J. |
author_sort | Robbins, Emma C. |
collection | PubMed |
description | Background Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously examined intermediate-risk patients from hospital data and identified a higher-risk subgroup who benefited from surveillance and a lower-risk subgroup who may not require surveillance. This study explored whether these findings apply in individuals undergoing CRC screening. Methods This retrospective study used data from the UK Flexible Sigmoidoscopy Screening Trial (UKFSST), English CRC screening pilot (ECP), and US Kaiser Permanente CRC prevention program (KPCP). Screening participants (50 – 74 years) classified as intermediate-risk at baseline colonoscopy were included. CRC data were available through 2006 (KPCP) or 2014 (UKFSST, ECP). Lower- and higher-risk subgroups were defined using our previously identified baseline risk factors: higher-risk participants had incomplete colonoscopies, poor bowel preparation, adenomas ≥ 20 mm or with high-grade dysplasia, or proximal polyps. We compared CRC incidence in these subgroups and in the presence vs. absence of surveillance using Cox regression. Results Of 2291 intermediate-risk participants, 45 % were classified as higher risk. Median follow-up was 11.8 years. CRC incidence was higher in the higher-risk than lower-risk subgroup (hazard ratio [HR] 2.08, 95 % confidence interval [CI] 1.07 – 4.06). Surveillance reduced CRC incidence in higher-risk participants (HR 0.35, 95 %CI 0.14 – 0.86) but not statistically significantly so in lower-risk participants (HR 0.41, 95 %CI 0.12 – 1.38). Conclusion As previously demonstrated for hospital patients, screening participants classified as intermediate risk comprised two risk subgroups. Surveillance clearly benefited the higher-risk subgroup. |
format | Online Article Text |
id | pubmed-8007389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-80073892021-03-31 Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study Robbins, Emma C. Wooldrage, Kate Stenson, Iain Pack, Kevin Duffy, Stephen Weller, David Levin, Theodore Conell, Carol Wright, Suzanne Nickerson, Claire Martin, Jessica Cross, Amanda J. Endoscopy Background Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously examined intermediate-risk patients from hospital data and identified a higher-risk subgroup who benefited from surveillance and a lower-risk subgroup who may not require surveillance. This study explored whether these findings apply in individuals undergoing CRC screening. Methods This retrospective study used data from the UK Flexible Sigmoidoscopy Screening Trial (UKFSST), English CRC screening pilot (ECP), and US Kaiser Permanente CRC prevention program (KPCP). Screening participants (50 – 74 years) classified as intermediate-risk at baseline colonoscopy were included. CRC data were available through 2006 (KPCP) or 2014 (UKFSST, ECP). Lower- and higher-risk subgroups were defined using our previously identified baseline risk factors: higher-risk participants had incomplete colonoscopies, poor bowel preparation, adenomas ≥ 20 mm or with high-grade dysplasia, or proximal polyps. We compared CRC incidence in these subgroups and in the presence vs. absence of surveillance using Cox regression. Results Of 2291 intermediate-risk participants, 45 % were classified as higher risk. Median follow-up was 11.8 years. CRC incidence was higher in the higher-risk than lower-risk subgroup (hazard ratio [HR] 2.08, 95 % confidence interval [CI] 1.07 – 4.06). Surveillance reduced CRC incidence in higher-risk participants (HR 0.35, 95 %CI 0.14 – 0.86) but not statistically significantly so in lower-risk participants (HR 0.41, 95 %CI 0.12 – 1.38). Conclusion As previously demonstrated for hospital patients, screening participants classified as intermediate risk comprised two risk subgroups. Surveillance clearly benefited the higher-risk subgroup. Georg Thieme Verlag KG 2021-04 2020-08-19 /pmc/articles/PMC8007389/ /pubmed/32814350 http://dx.doi.org/10.1055/a-1217-0155 Text en © 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Robbins, Emma C. Wooldrage, Kate Stenson, Iain Pack, Kevin Duffy, Stephen Weller, David Levin, Theodore Conell, Carol Wright, Suzanne Nickerson, Claire Martin, Jessica Cross, Amanda J. Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study |
title | Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study |
title_full | Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study |
title_fullStr | Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study |
title_full_unstemmed | Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study |
title_short | Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study |
title_sort | heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007389/ https://www.ncbi.nlm.nih.gov/pubmed/32814350 http://dx.doi.org/10.1055/a-1217-0155 |
work_keys_str_mv | AT robbinsemmac heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT wooldragekate heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT stensoniain heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT packkevin heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT duffystephen heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT wellerdavid heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT levintheodore heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT conellcarol heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT wrightsuzanne heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT nickersonclaire heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT martinjessica heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy AT crossamandaj heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy |